• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项观察性纵向研究,该研究通过社区获得性肺炎疾病负担问卷对全国范围内接受调查的老年人报告的症状负担和社区获得性肺炎恢复时间进行了研究。

Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire.

作者信息

Wyrwich Kathleen W, Yu Holly, Sato Reiko, Powers John H

机构信息

Evidera, Inc., Bethesda, MD, USA.

Pfizer Inc., Collegeville, PA, USA.

出版信息

Patient Relat Outcome Meas. 2015 Jul 30;6:215-23. doi: 10.2147/PROM.S85779. eCollection 2015.

DOI:10.2147/PROM.S85779
PMID:26257528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4525785/
Abstract

BACKGROUND

Millions of older adults who develop community-acquired pneumonia (CAP) each year survive, but there is a large knowledge gap on the burden of CAP and the recovery process in survivors from the patient perspective.

METHODS

The newly developed CAP Burden of Illness Questionnaire was administered through a Web survey to a nationwide sample of US adults aged ≥50 years who were recently diagnosed with CAP. Survey respondents with unresolved symptoms or other CAP-related health problems completed a second survey 30 days later; a third survey was completed another 30 days later by respondents with unresolved symptoms or problems. Nationally representative results describing the average time to recovery of symptoms and other CAP-related problems were achieved using post-stratification weights.

RESULTS

Five hundred participants completed the initial survey. The time to resolution for the CAP symptoms of weakness, shortness of breath, and tiredness exceeded 3 weeks on average. There was an average of 13 days of absenteeism, and 3 weeks (mean =21 days) before achieving full work/activity productivity after CAP. For participants with health conditions that worsened from pneumonia, chronic emphysema and chronic obstructive pulmonary disease took the longest to return to baseline (mean =60 and 52.4 days, respectively).

CONCLUSION

The results from this study demonstrate that older adults surviving a CAP episode experience a significant multi-symptom illness with long recovery periods to achieve pre-CAP health and productivity. These findings highlight the need for further research on effective clinician-patient communication, the need for patient-centered outcomes in clinical trials for CAP therapeutics, adequate home care during the recovery process, and the pursuit of CAP prevention strategies.

摘要

背景

每年有数百万患社区获得性肺炎(CAP)的老年人存活下来,但从患者角度来看,关于CAP的负担以及幸存者的康复过程,仍存在巨大的知识空白。

方法

通过网络调查,向全国范围内年龄≥50岁且最近被诊断为CAP的美国成年人样本发放新开发的CAP疾病负担问卷。有未解决症状或其他与CAP相关健康问题的调查受访者在30天后完成第二次调查;有未解决症状或问题的受访者在再过30天后完成第三次调查。使用事后分层权重得出描述症状及其他与CAP相关问题平均恢复时间的全国代表性结果。

结果

500名参与者完成了初始调查。虚弱、呼吸急促和疲劳等CAP症状的缓解时间平均超过3周。平均旷工13天,CAP后平均需要3周(平均=21天)才能恢复到完全的工作/活动能力。对于因肺炎导致健康状况恶化的参与者,慢性肺气肿和慢性阻塞性肺疾病恢复到基线所需时间最长(分别平均为60天和52.4天)。

结论

本研究结果表明,CAP发作后存活的老年人经历了一种多症状的严重疾病,恢复到CAP前的健康和能力水平需要很长时间。这些发现凸显了进一步研究有效医患沟通的必要性、CAP治疗临床试验中以患者为中心结局的必要性、康复过程中充足家庭护理的必要性以及CAP预防策略的必要性。

相似文献

1
Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire.一项观察性纵向研究,该研究通过社区获得性肺炎疾病负担问卷对全国范围内接受调查的老年人报告的症状负担和社区获得性肺炎恢复时间进行了研究。
Patient Relat Outcome Meas. 2015 Jul 30;6:215-23. doi: 10.2147/PROM.S85779. eCollection 2015.
2
Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older.社区获得性肺炎:50 岁及以上美国成年人诊断时的症状和疾病负担。
Patient. 2013;6(2):125-34. doi: 10.1007/s40271-013-0013-4.
3
Patient-Reported Consequences of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者社区获得性肺炎的患者报告结局
Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):132-144. doi: 10.15326/jcopdf.6.2.2018.0144.
4
Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.轻至中重度社区获得性肺炎患者的长期症状恢复及健康相关生活质量
Chest. 2006 Oct;130(4):1165-72. doi: 10.1378/chest.130.4.1165.
5
Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.医疗保险按服务项目付费人群中社区获得性肺炎的临床和经济负担。
J Am Geriatr Soc. 2012 Nov;60(11):2137-43. doi: 10.1111/j.1532-5415.2012.04208.x. Epub 2012 Oct 30.
6
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.慢性阻塞性肺疾病(COPD)患者社区获得性肺炎的季节性、危险因素及负担:一项使用关联医疗记录的人群数据库研究
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:313-322. doi: 10.2147/COPD.S121389. eCollection 2017.
7
Assessing, treating and preventing community acquired pneumonia in older adults: findings from a community-wide survey of emergency room and family physicians.评估、治疗和预防老年人社区获得性肺炎:一项针对急诊室医生和家庭医生的全社区调查结果
BMC Fam Pract. 2005 Aug 2;6:32. doi: 10.1186/1471-2296-6-32.
8
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.社区获得性肺炎症状问卷:一种基于患者的新型结局指标,用于评估社区获得性肺炎患者的症状。
Chest. 2002 Sep;122(3):920-9. doi: 10.1378/chest.122.3.920.
9
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.社区获得性肺炎住院患者的发病率、直接费用及住院时长:一项全国性回顾性索赔数据库分析
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.
10
Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.退伍军人健康管理局中社区获得性肺炎的临床和经济负担,2011年:一项回顾性队列研究
Infection. 2015 Dec;43(6):671-80. doi: 10.1007/s15010-015-0789-3. Epub 2015 May 17.

引用本文的文献

1
Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis.13价、15价和20价肺炎球菌结合疫苗在加拿大儿科人群中的比较:一项成本效用分析。
Can Commun Dis Rep. 2025 Feb 12;51(2-3):68-83. doi: 10.14745/ccdr.v51i23a02. eCollection 2025 Feb.
2
Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia.社区获得性肺炎患者对药剂师主导的管理建议的接受情况。
Antimicrob Steward Healthc Epidemiol. 2024 Oct 17;4(1):e181. doi: 10.1017/ash.2024.399. eCollection 2024.
3
Time to recovery from severe community-acquired pneumonia and its determinants among older adults admitted to North Wollo hospitals: A multi-centred cohort study.老年社区获得性肺炎患者的恢复时间及其决定因素:一项多中心队列研究。
J Glob Health. 2024 Sep 27;14:04203. doi: 10.7189/jogh.14.04203.
4
Neurological Signs of Postcovid Syndrome.新冠后综合征的神经学体征。
Neurosci Behav Physiol. 2022;52(7):968-975. doi: 10.1007/s11055-022-01324-1. Epub 2022 Dec 24.
5
Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt.新冠病毒感染清除后持续症状的患病率及预测因素:一项来自埃及的多中心研究
Infect Drug Resist. 2022 May 20;15:2575-2587. doi: 10.2147/IDR.S355064. eCollection 2022.
6
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.对出院后3个月和12个月的COVID-19住院幸存者进行前瞻性纵向评估。
ERJ Open Res. 2022 Apr 11;8(2). doi: 10.1183/23120541.00004-2022. eCollection 2022 Apr.
7
COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia.新型冠状病毒肺炎:沙特阿拉伯患者康复后的长期症状。
PLoS One. 2021 Dec 8;16(12):e0260259. doi: 10.1371/journal.pone.0260259. eCollection 2021.
8
The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of Mashhad University of Medical Sciences.因 COVID-19 导致伊朗医护人员缺勤而造成的生产力损失:马什哈德医科大学医院的案例研究。
BMC Health Serv Res. 2021 Oct 28;21(1):1169. doi: 10.1186/s12913-021-07200-x.
9
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.在患有社区获得性细菌性肺炎和常见临床合并症的汇总 3 期临床试验人群中, lefamulin 的疗效和安全性。
BMC Pulm Med. 2021 May 8;21(1):154. doi: 10.1186/s12890-021-01472-z.
10
Symptomatic, biochemical and radiographic recovery in patients with COVID-19.COVID-19 患者的症状、生化和影像学恢复。
BMJ Open Respir Res. 2021 Apr;8(1). doi: 10.1136/bmjresp-2021-000908.

本文引用的文献

1
Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older.社区获得性肺炎:50 岁及以上美国成年人诊断时的症状和疾病负担。
Patient. 2013;6(2):125-34. doi: 10.1007/s40271-013-0013-4.
2
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial.阿莫西林治疗初级保健中疑似肺炎的下呼吸道急性感染:一项 12 国、随机、安慰剂对照试验。
Lancet Infect Dis. 2013 Feb;13(2):123-9. doi: 10.1016/S1473-3099(12)70300-6. Epub 2012 Dec 19.
3
Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.医疗保险按服务项目付费人群中社区获得性肺炎的临床和经济负担。
J Am Geriatr Soc. 2012 Nov;60(11):2137-43. doi: 10.1111/j.1532-5415.2012.04208.x. Epub 2012 Oct 30.
4
Incidence and cost of CAP in a large working-age population.CAP 在一个大型劳动年龄人群中的发病率和费用。
Am J Manag Care. 2012 Jul;18(7):380-7.
5
Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).更新的 23 价肺炎球菌多糖疫苗(PPSV23)预防成人侵袭性肺炎球菌病的建议。
MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.
6
Burden of community-acquired pneumonia in North American adults.成人社区获得性肺炎负担。
Postgrad Med. 2010 Mar;122(2):130-41. doi: 10.3810/pgm.2010.03.2130.
7
Physical activity and the risk of community-acquired pneumonia in US women.身体活动与美国女性社区获得性肺炎风险的关系
Am J Med. 2010 Mar;123(3):281.e7-281.e11. doi: 10.1016/j.amjmed.2009.07.028.
8
The impact of time on the systemic inflammatory response in pneumococcal pneumonia.时间对肺炎链球菌性肺炎全身炎症反应的影响。
Eur Respir J. 2010 Mar;35(3):614-8. doi: 10.1183/09031936.00052709. Epub 2009 Jul 16.
9
General and health-related life satisfaction of patients with community-acquired pneumonia.
Psychol Health Med. 2009 May;14(3):331-42. doi: 10.1080/13548500802657669.
10
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.了解肺炎和脓毒症中的炎性细胞因子反应:脓毒症基因与炎性标志物(GenIMS)研究结果
Arch Intern Med. 2007;167(15):1655-63. doi: 10.1001/archinte.167.15.1655.